HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX -278.80 -1.16%
23824.10
 
NIFTY -893.39 -1.16%
76200.68
 
Nasdaq -351.33 -1.32%
26166.60
 
Nikkei 225 1103.90 1.55%
72353.96
 
FTSE 100 74.60 0.72%
10437.90
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Indrayani Biotech Ltd.
 
Source DateBoard Meeting DateDetails
06-Apr-2026 09-Apr-2026 Scheme of Arrangement
23-Feb-2026 26-Feb-2026 Quarterly Results
05-Dec-2025 11-Dec-2025 Quarterly Results
13-Nov-2025 14-Nov-2025 Quarterly Results
26-Aug-2025 30-Aug-2025 Inter alia, to consider and approve:- 1.Notice of the 33rd Annual General Meeting of the company. 2.Disinvestment from Material Subsidiary - Dindigul Farm Product Limited. 3.Reclassification from Promoter status to Public shareholder status at Dindigul Farm Product Limited. 4.Rescindment Of Resolution Passed at the 32nd Annual General Meeting for Increasing the Authorized Share Capital. 5.Increase of Authorised share capital of the Company from Rs.65 crores to Rs.85 crores comprising 8.50 crores equity shares of Rs. 10/- each (Eight Crores and Fifty Lakhs) and consequential amendment of the capital clause in the Memorandum of Association of the Company. 6.Appointment of Mr. Swaminathan (DIN: 02481041) as Whole-Time Director. 7.Appointment of Mr. Singarababu Indirakumar (DIN: 00892351) as Whole-Time Director.
11-Aug-2025 14-Aug-2025 Quarterly Results
09-Jun-2025 12-Jun-2025 Audited Results
28-May-2025 09-Jun-2025 Audited Results(Cancelled) (Cancelled)
27-Mar-2025 03-Apr-2025 Right Issue of Equity Shares
27-Feb-2025 27-Feb-2025 Quarterly Results
10-Feb-2025 14-Feb-2025 Quarterly Results
11-Nov-2024 14-Nov-2024 Quarterly Results & Right Issue of Equity Shares
08-Aug-2024 14-Aug-2024 Quarterly Results
24-Jul-2024 27-Jul-2024 Inter alia, to consider and approve the following items of business:- 1. To approve the increase and reclassification of authorized share capital of the company subject to the approval of the shareholders. 2. To increase the limit of investment in the total paid up capital of the Company by foreign portfolio investors, foreign institutional investors and non-resident Indians subject to the approval of the shareholders. 3. To consider and approve material related party transactions between the Company and subsidiaries subject to the approval of the shareholders. 4. To consider and approve Directors? report and annexures thereon. 5. To take note of the Secretarial audit report 6. To fix the date, time, venue and mode of 32ndAnnual General Meeting of the Company and approve the draft Notice for convening the said General Meeting. 7. To appoint the Scrutinizer for 32nd Annual General Meeting of the Company. 8. Other business matters.
23-May-2024 30-May-2024 Audited Results
05-Feb-2024 10-Feb-2024 Quarterly Results
08-Jan-2024 10-Jan-2024 Increase in Authorised Capital & Inter alia, to transact the following business: 1. To consider the proposal for increasing the authorized share capital subject to the shareholders? approval. 2. To consider and approve the conversion of unsecured loans into equity under Section 62(3) of the Companies Act, 2013 subject to the shareholders? approval. 3. Any other business with the permission of the Chair.
09-Nov-2023 14-Nov-2023 Quarterly Results
27-Oct-2023 01-Nov-2023 Dividend on Preference Shares & Inter alia, to consider and approve:- 1. To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. 2. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. 3. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. 4. Any other matter with the permission of the chair.
07-Aug-2023 11-Aug-2023 Quarterly Results
Page 1 of 7
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.